Study of the Glutaminase Inhibitor CB-839 in Leukemia

Clinical trial NCT02071927 · COMPLETED

Trial details

NCT number: NCT02071927
Sponsor: Calithera Biosciences, Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)Acute Lymphocytic Leukemia (ALL)

Start date: 2014-03-01
Primary completion: 2016-10-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.